- Home
- MKFG vs QNCX Comparison
MKFG vs QNCX Comparison
Compare MKFG & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKFG
- QNCX
- Stock Information
- Founded
- MKFG 2013
- QNCX 2012
- Country
- MKFG United States
- QNCX United States
- Employees
- MKFG N/A
- QNCX N/A
- Industry
- MKFG Retail: Computer Software & Peripheral Equipment
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MKFG Technology
- QNCX Health Care
- Exchange
- MKFG Nasdaq
- QNCX Nasdaq
- Market Cap
- MKFG 60.6M
- QNCX 62.0M
- IPO Year
- MKFG N/A
- QNCX 2019
- Fundamental
- Price
- MKFG $2.61
- QNCX $1.40
- Analyst Decision
- MKFG Hold
- QNCX Strong Buy
- Analyst Count
- MKFG 2
- QNCX 4
- Target Price
- MKFG $5.00
- QNCX $9.50
- AVG Volume (30 Days)
- MKFG 89.2K
- QNCX 110.3K
- Earning Date
- MKFG 03-06-2025
- QNCX 03-31-2025
- Dividend Yield
- MKFG N/A
- QNCX N/A
- EPS Growth
- MKFG N/A
- QNCX N/A
- EPS
- MKFG N/A
- QNCX N/A
- Revenue
- MKFG $86,889,000.00
- QNCX N/A
- Revenue This Year
- MKFG N/A
- QNCX N/A
- Revenue Next Year
- MKFG $9.45
- QNCX N/A
- P/E Ratio
- MKFG N/A
- QNCX N/A
- Revenue Growth
- MKFG N/A
- QNCX N/A
- 52 Week Low
- MKFG $1.57
- QNCX $0.51
- 52 Week High
- MKFG $8.80
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- MKFG 31.61
- QNCX 37.98
- Support Level
- MKFG $2.90
- QNCX $1.38
- Resistance Level
- MKFG $3.08
- QNCX $1.54
- Average True Range (ATR)
- MKFG 0.16
- QNCX 0.11
- MACD
- MKFG 0.00
- QNCX -0.00
- Stochastic Oscillator
- MKFG 12.20
- QNCX 9.37
About MKFG Markforged Holding Corporation
Markforged Holding Corp transforms manufacturing with 3D metal and continuous carbon fiber printers capable of producing parts tough enough for the factory floor. intuitive additive manufacturing platform for modern manufacturers, bringing the power and speed of agile software development to industrial manufacturing. Composed of hardware, software and materials working as a unified platform. It operates in industries such as Aerospace, Automotive, Consumer Packaged Goods, Education and Research, Electronics Manufacturing, Energy, Federal and Defense, Industrial Equipment. The company's geographical segments include the Americas; Europe, the Middle East, Africa; and Asia-Pacific. It derives maximum revenue from Americas.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.